verified SJR 0,784 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q2 — Hematology lock Subscription

Leukemia Research

Leukemia Research is a journal indexed in SJR in Hematology and Oncology with an H index of 98. It has an SJR impact factor of 0,784 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,784.

Leukemia Research focuses its scope in these topics and keywords: leukemia, antibody, myeloid, induces, monoclonal, cells, chronic, apoptosis, anticd, inhibition, ...

ISSN: 0145-2126

Publisher: Elsevier Ltd

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,784 Q2

H-index 98

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,784

H-index

Docs (year)

104

Docs 3y

412

Total refs

3865

Cites 3y

657

Citable 3y

303

Cites/Doc 2y

1.62

Ref/Doc

37.16

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

135 Molecular genetics of myeloid disorders characterized by -7/del(7q)

Younger age observation IN myelodysplastic syndrome

45 Myelodysplastic syndrome in its fibrotic variant: A borderline to chronic myeloproliferation

40 Atypical sweet's syndrome (SS) in a patient with AML secondary to a RAEB-T

26 Cytoplasmic abnormalities of erythroblasts in a patient with refractory anaemia with ring sideroblasts

202 Calcitriol in the treatment of myelodysplastic syndromes

178 Oral idarubicin administration as monochemotherapy in myelodisplastic syndromes

176 Induction of complete hematological and cytogenic remissions in myelopysplastic syndromes and CMML by topotecan

169 Aggressive chemotherapy in MDS: The Dusseldorf experience

163 Amifostine in low-risk and combined therapy with gemcitabine in high-risk myelodysplastic syndromes

154 Chromosome anomalies in hematologic malignancies

14 Problems in the classification of CMML. Dysplastic vs profliferative type

SHOW MORE ARTICLES

138 Mutant RAS or FMS confer abnormal growth in haematopoietic cells: Poor clinical outcome in myelodysplasia with RAS , FMS and p53 mutations

1 Laboratory presentation and morphological characteristics of myelodysplastic syndromes

132 A case of a t(1;3)(p36:q21) in chronic myelomonocytic leukemia with thrombocytosis and TPO gene expression in malignant cells

128 Single del(11q) in a patient with RAEB which progressed to erythroleukemia

127 Both inhaled and ingested substances are involved in secondary myelodysplastic syndromes (MDS) with 6p changes

125 Clonal karyotypic abnormalities after autologous transplantation (AT)

121 Myelodysplastic syndrome and 17P deletion

118 Cytogenetic study and prognostic impact of complex karyotypes in 22 myelodysplastic syndromes

116 Cytogenetic studies in 429 myelodysplastic syndromes:Prognostic value

113 Morphological, cytogenetic, molecular and etiological features of the <<17p syndrome >> in MDS

108 Defective actin polymerization in neutrophils from patients with myelodysplastic syndromes

106 Mast cell (MC) lineage involvement in myelo-dysplastic syndromes: Diagnostic utility of tryptase staining

FAQs

Leukemia Research has an SJR of 0,784 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Leukemia Research is 25%.

Leukemia Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Leukemia Research?

What is the APC / publication cost?

What is the acceptance rate?